F. de Vries

First name
Last name
de Vries
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A. C., et al. (2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiol, 78, 102149. http://doi.org/10.1016/j.canep.2022.102149
van Staa, T. P., Wegman, S., de Vries, F., Leufkens, B., & Cooper, C. (2001). Use of statins and risk of fractures. Jama.
de Vries, F., van Staa, T. P., Bracke, M. S., Cooper, C., Leufkens, H. G., & Lammers, J. W. (2005). Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J. http://doi.org/10.1183/09031936.05.00058204
de Vries, F., de Vries, C., Cooper, C., Leufkens, B., & van Staa, T. P. (2006). Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J Epidemiol. http://doi.org/10.1093/ije/dyl147
de Vries, F., Souverein, P. C., Cooper, C., Leufkens, H. G., & van Staa, T. P. (2007). Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int. http://doi.org/10.1007/s00223-006-0213-1
Wilting, I., de Vries, F., Thio, B. M., Cooper, C., Heerdink, E. R., Leufkens, H. G., et al. (2007). Lithium use and the risk of fractures. Bone. http://doi.org/10.1016/j.bone.2006.12.055
de Vries, F., Bracke, M., Leufkens, H. G., Lammers, J. W., Cooper, C., & van Staa, T. P. (2007). Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. http://doi.org/10.1002/art.22294
Zhang, B., de Vries, F., Setakis, E., & van Staa, T. P. (2009). The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database. J Hypertens. http://doi.org/10.1097/HJH.0b013e32832af68d
de Vries, F., Cooper, A. L., Cockle, S. M., van Staa, T. P., & Cooper, C. (2009). Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int. http://doi.org/10.1007/s00198-009-0891-4
de Vries, F., Setakis, E., Zhang, B., & van Staa, T. P. (2010). Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD. Eur Respir J. http://doi.org/10.1183/09031936.00124209